B9X-24662-55428
3 vaccinations
3 coded responses
3 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 105 / NY
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-08-11
Registered in v-safe
-
2021-09-25
Survey response — 6 months, dose 2MedDRA: Respiratory tract congestion, Sneezing — Feeling: FairFree text: Sneezing, congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Dose 3 — Pfizer-BioNTech
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: Delivery, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Gave birth. PPDMedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-29
-
2022-04-24
Survey response — 6 months, dose 3MedDRA: Delivery, Perinatal depression — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Gave birth. Severe PPD.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-04-25
- 2022-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | No |
| 2 | 2021-03-27 | Pfizer-BioNTech | No |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Sneezing, congestion
Release 11 — 12 months, dose 2
Symptoms: Gave birth. PPD
Release 11 — 6 months, dose 3
Symptoms: Gave birth. Severe PPD.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Perinatal depression | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release